Skip to main content
SINGULAR HEALTH GROUP LTD logo

SINGULAR HEALTH GROUP LTD — Investor Relations & Filings

Ticker · SHG ISIN · AU0000129892 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 364 across all filing types
Latest filing 2025-02-19 Share Issue/Capital Cha…
Country AU Australia
Listing ASX SHG

About SINGULAR HEALTH GROUP LTD

https://singular.health/

Singular Health Group Ltd specializes in the development and commercialization of medical imaging software designed to enhance personalized healthcare. The company’s primary offering, the 3Dicom software suite, employs proprietary volume rendering technology to transform standard 2D DICOM files, such as CT and MRI scans, into immersive 3D visualizations. This platform supports surgical planning, remote clinical collaboration, and patient education by providing interactive anatomical models. Singular Health integrates artificial intelligence to automate image segmentation and diagnostic workflows, facilitating more precise clinical outcomes. Through its 'Scan to Surgery' initiative, the company bridges the gap between diagnostic imaging and physical intervention using virtual reality and 3D printing. Its solutions target medical practitioners, dental professionals, and healthcare institutions globally.

Recent filings

Filing Released Lang Actions
Notification regarding unquoted securities - SHG 6 pages 20.1KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities' and details the issuance of unquoted options under an employee incentive scheme by Singular Health Group Ltd. It includes specifics such as the number of securities issued, exercise price, expiry date, and references to ASX listing rules. The content is focused on notifying the market about a securities issuance event rather than providing financial statements or performance data. This matches the definition of a Share Issue/Capital Change announcement, which covers new share issues or capital changes. The document length (6715 characters) and detailed issuance data support this classification rather than a brief announcement or a regulatory filing. Therefore, the appropriate filing type is SHA (Share Issue/Capital Change).
2025-02-19 English
Notice of General Meeting/Proxy Form 33 pages 597.3KB
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled 'NOTICE OF GENERAL MEETING AND EXPLANATORY STATEMENT' and details the time, place, and procedures for a general meeting of shareholders. It includes multiple resolutions for shareholder approval, such as ratification of share placements and issuance of options to directors and others. The content focuses on informing shareholders about the meeting logistics, voting rights, proxy appointments, and the business to be conducted at the meeting. There are no financial statements, earnings data, or management discussion of financial results. The document is a formal notice and explanatory statement for a shareholder meeting, which fits the definition of Proxy Solicitation & Information Statement (PSI) as it provides information to shareholders to solicit their votes for the meeting resolutions.
2025-02-16 English
Letter to Shareholders 1 page 94.9KB
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice announcing a General Meeting of Singular Health Group Ltd, including details about the meeting date, location, proxy form, and how shareholders can access the Notice of Meeting and related materials. It does not contain the actual Notice of Meeting or Explanatory Memorandum itself, nor does it include voting results or financial data. The document is primarily an announcement about the upcoming meeting and how shareholders can participate. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI), as it provides information and materials related to a shareholder meeting and solicits votes via proxy forms.
2025-02-16 English
Proposed issue of securities - SHG 7 pages 27.5KB
Capital/Financing Update Classification · 100% confidence The document is an Appendix 3B form, which is a standard ASX announcement format used for the proposed issue of securities. It details the proposed placement of new securities, including options and performance rights, with specifics on the number of securities, exercise prices, expiry dates, and the purpose of the issue (long-term incentive packages and consulting services). The document is focused on capital raising and securities issuance rather than financial results, management changes, or other report types. It is not a full financial report but an announcement related to capital structure changes. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and detail confirm it is not a brief notice or a regulatory filing fallback.
2025-02-16 English
Appendix 3Y - Change of Director's Interest Notice x 3 7 pages 20.5KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director's Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in directors' relevant interests in securities, including the number of securities held before and after changes, nature of changes (such as expiry of options), and closed period trading information. The document is a formal notification of personal share transactions by company directors. It does not contain financial performance data, earnings, or management discussion, but focuses solely on directors' share dealings. Therefore, it fits the definition of Director's Dealing (DIRS). The document length is sufficient and contains detailed information about directors' securities transactions, confirming the classification with high confidence.
2025-02-12 English
Notification of cessation of securities - SHG 4 pages 14.9KB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 3H - Notification of cessation of securities' and details the cessation of certain securities (options) for Singular Health Group Ltd. It includes specifics such as the security code, number of securities ceased, reason for cessation (expiry of options), and updated issued capital figures. The document is a formal announcement notifying the market and regulatory body (ASX) about the cessation of securities. It does not contain financial statements, management discussion, or detailed financial results. It is not a report but an official notification about changes in securities status. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement that does not fit other specific categories like capital changes or director dealings, since it is specifically about cessation of securities (options) and is an ASX Appendix 3H form, which is a standard regulatory filing for such events.
2025-02-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.